Insider Trading History of Sieczkarek Mark M

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Sieczkarek Mark M since 2005. The trader's CIK number is 1188738. At the time of the last reporting, Sieczkarek Mark M was the President/CEO of Novabay Pharmaceuticals, Inc.. (stock ticker symbol NBY). Also see all insider trading activities at Novabay Pharmaceuticals, Inc..

Note that in the past SIECZKAREK MARK M also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Thermage Inc (SLTM) by Sieczkarek Mark M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 SLTM 150,000 $261,000 0 $0 0 $0

Yearly summary of insider trading at Novabay Pharmaceuticals, Inc. (NBY) by Sieczkarek Mark M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 NBY 166,666 $99,999 0 $0 0 $0
2014 NBY 29,800 $26,272 0 $0 0 $0

Yearly summary of insider trading at Conceptus Inc (CPTS) by Sieczkarek Mark M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 CPTS 0 $0 168,100 $3,501,578 98,311 $978,194
2009 CPTS 0 $0 101,689 $1,933,780 101,689 $1,011,804
2007 CPTS 0 $0 31,317 $612,247 0 $0
2005 CPTS 20,000 $161,000 0 $0 0 $0


Insider trading activities at 3 companies by Sieczkarek Mark M:

1. Thermage Inc (SLTM)

2. Novabay Pharmaceuticals, Inc. (NBY)

3. Conceptus Inc (CPTS)

Table 1. Insider trading of Thermage Inc (SLTM) by Sieczkarek Mark M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-05-06 SLTM Buy 150,000 1.74 261,000

Table 2. Insider trading of Novabay Pharmaceuticals, Inc. (NBY) by Sieczkarek Mark M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-03-03 NBY Buy 166,666 .60 99,999
2014-06-04 NBY Buy 4,800 .89 4,272
2014-05-19 NBY Buy 25,000 .88 22,000

Table 3. Insider trading of Conceptus Inc (CPTS) by Sieczkarek Mark M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-02-19 CPTS Sale 69,789 22.00 1,535,358
2010-01-20 CPTS Option Ex 98,311 9.95 978,194
2010-01-20 CPTS Sale 98,311 20.00 1,966,220
2009-10-22 CPTS Option Ex 1,689 9.95 16,805
2009-10-22 CPTS Sale 1,689 20.00 33,780
2009-09-23 CPTS Option Ex 95,387 9.95 949,100
2009-09-23 CPTS Sale 95,387 19.00 1,812,353
2009-09-09 CPTS Option Ex 4,613 9.95 45,899
2009-09-09 CPTS Sale 4,613 19.00 87,647
2007-12-13 CPTS Sale 31,317 19.55 612,247
2005-08-09 CPTS Buy 10,000 8.10 81,000
2005-08-09 CPTS Buy 10,000 8.00 80,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sieczkarek Mark M (President/CEO of Novabay Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.